DA32 Life Science Tech Acquisition Corp.
345 Park Avenue South, 12th Floor
New York, NY 10010
July 23, 2021
VIA EDGAR
Folake K. Ayoola
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
| Re: | DA32 Life Science Tech Acquisition Corp. |
Registration Statement on Form S-1
Filed July 2, 2021, as amended
File No. 333-257679
Dear Ms. Ayoola:
Pursuant to Rule 461 of the rules and regulations promulgated under the Securities Act of 1933, as amended, DA32 Life Science Tech Acquisition Corp. respectfully requests that the effective date of the above-referenced Registration Statement be accelerated so as to permit it to become effective at 4:00 p.m. Washington D.C. time on July 27, 2021, or as soon thereafter as practicable.
Please call Henrikki Harsu of White & Case LLP at (212) 819-7628 to provide notice of the effectiveness of the Registration Statement.
[Signature Page Follows]
| Very truly yours, | ||
| By: | /s/ Christopher Wolfe | |
| Name: Christopher Wolfe | ||
| Title: Chief Financial Officer | ||
cc: Henrikki Harsu, White & Case LLP
[Signature Page to Acceleration Request]
